[FIB-4  index to rule-out advanced liver fibrosis in NAFLD patients].

[FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients].
Presse Med. 2019 Nov 22;:
Authors: Mallet V, Parlati L, Vallet-Pichard A, Terris B, Tsochatzis E, Sogni P, Pol S
Abstract
The FIB-4 index is a biomarker of advanced hepatic fibrosis in a context of fatty liver disease. The calculation of the FIB-4 index requires of age, serum ALT and AST transaminase levels and platelet count. A FIB-4 index<1.45 in a context of fatty liver disease excludes clinically significant hepatic fibrosis. Additional explorations are mandatory to excluded hepatic fibrosis for a a FIB-4 index>1.45 in a context of fatty liver disease. A complete hepatological workup is mafatory for a FIB-4 index>3.25 in a context of fatty liver disease.
PMID: 31767251 [PubMed - as supplied by publisher]

Source: Presse Medicale - November 21, 2019 Category: General Medicine Authors: Mallet V, Parlati L, Vallet-Pichard A, Terris B, Tsochatzis E, Sogni P, Pol S Tags: Presse Med Source Type: research